• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.

作者信息

Zhou Feng, Liu Ye-Mao, Xie Jing, Li Haomiao, Lei Fang, Yang Huilin, Qin Juan-Juan, Cai Jingjing, Zhang Xiao-Jing, Wu Bin, Xia Meng, Xiang Da, Yang Chengzhang, Ma Xinliang, Xu Qingbo, Lu Zhigang, Lu Haofeng, Xia Xigang, Wang Daihong, Liao Xiaofeng, Peng Gang, Yang Jun, Huang Xiaodong, Zhang Bing-Hong, Yuan Yufeng, Wei Xiang, Liu Peter P, Wang Yibin, Zhang Peng, She Zhi-Gang, Xia Jiahong, Li Hongliang

机构信息

From the Medical Science Research Center, Zhongnan Hospital of Wuhan University, China (F.Z., P.Z., Hongliang Li).

Institute of Model Animal (F.Z., Y.-M.L., Haomiao Li, F.L., H.Y., J.-J.Q., X.-J.Z., B.W., M.X., D.X., C.Y., P.Z., Z.-G.S., Hongliang Li), Wuhan University, China.

出版信息

Hypertension. 2020 Aug;76(2):e15-e17. doi: 10.1161/HYPERTENSIONAHA.120.15622. Epub 2020 Jun 3.

DOI:10.1161/HYPERTENSIONAHA.120.15622
PMID:32493070
Abstract
摘要

相似文献

1
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.血管紧张素转换酶（ACE）抑制剂与血管紧张素II受体阻滞剂对2019冠状病毒病死亡风险的比较影响
Hypertension. 2020 Aug;76(2):e15-e17. doi: 10.1161/HYPERTENSIONAHA.120.15622. Epub 2020 Jun 3.
2
Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.对近期有关血管紧张素转换酶2（ACE2）和肾素-血管紧张素系统阻滞剂与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染相关性的评论的回应
Drug Dev Res. 2020 Sep;81(6):643-646. doi: 10.1002/ddr.21672. Epub 2020 Apr 17.
3
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus.血管紧张素转换酶抑制剂、血管紧张素 II 受体阻滞剂与冠状病毒
J Hypertens. 2020 Jun;38(6):1190-1191. doi: 10.1097/HJH.0000000000002469.
4
Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.最新警报：成人中血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的风险及影响
Ann Intern Med. 2020 Aug 4;173(3):W66. doi: 10.7326/L20-0887. Epub 2020 Jun 25.
5
Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.血管紧张素转换酶2与炎症消退：支持继续使用处方血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂
Mayo Clin Proc. 2020 Jul;95(7):1552-1553. doi: 10.1016/j.mayocp.2020.05.001. Epub 2020 May 21.
6
COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.COVID-19 与血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂治疗。
Ann Intern Med. 2020 Aug 4;173(3):237-238. doi: 10.7326/M20-3047. Epub 2020 May 15.
7
Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.最新警报2：成人中血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的风险及影响
Ann Intern Med. 2020 Sep 1;173(5):W87. doi: 10.7326/L20-0969. Epub 2020 Jul 23.
8
[Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].[年龄、合并症及肾素-血管紧张素-醛固酮系统在新型冠状病毒肺炎中的作用。血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的影响]
Kardiologiia. 2020 Apr 8;60(4):4-9. doi: 10.18087/cardio.2020.4.n1122.
9
Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity.心跳：肾素-血管紧张素-醛固酮阻断药物与新冠病毒疾病易感性及严重程度的相互作用
Heart. 2020 Oct;106(19):1451-1453. doi: 10.1136/heartjnl-2020-318164.
10
Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.更新警报3：成人中血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的风险及影响
Ann Intern Med. 2020 Oct 6;173(7):130-131. doi: 10.7326/L20-1068. Epub 2020 Aug 26.

引用本文的文献

1
Use of drugs for hypertension or heart failure and the risk of death in COVID-19: association with loop-diuretics.使用降压药或心衰药与 COVID-19 患者死亡风险：与袢利尿剂相关。
Eur J Clin Pharmacol. 2024 Oct;80(10):1515-1522. doi: 10.1007/s00228-024-03709-2. Epub 2024 Jun 24.
2
Impact of angiotensin receptor blocker as antihypertensive in assessing mortality in patients of COVID-19: A single tertiary care center study.血管紧张素受体阻滞剂作为抗高血压药物在评估COVID-19患者死亡率中的作用：一项单中心三级医疗中心研究。
J Educ Health Promot. 2023 Jan 31;12:30. doi: 10.4103/jehp.jehp_922_22. eCollection 2023.
3
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic.
高血压的代偿性肾素-血管紧张素系统：COVID-19 大流行时代的回顾与更新。
Biochem Pharmacol. 2023 Feb;208:115370. doi: 10.1016/j.bcp.2022.115370. Epub 2022 Dec 5.
4
Drugs acting on the renin-angiotensin-aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies.作用于肾素-血管紧张素-醛固酮系统（RAAS）的药物与COVID-19患者死亡：观察性研究的系统评价和荟萃分析
Egypt Heart J. 2022 Sep 6;74(1):64. doi: 10.1186/s43044-022-00303-8.
5
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.肾素-血管紧张素-醛固酮抑制剂与 COVID-19 感染。
Curr Hypertens Rep. 2022 Oct;24(10):425-433. doi: 10.1007/s11906-022-01207-3. Epub 2022 Jun 18.
6
Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.肾素-血管紧张素-醛固酮系统抑制剂与 COVID-19：系统评价和荟萃分析揭示了大量观察性研究中的关键偏倚。
J Am Heart Assoc. 2022 Jun 7;11(11):e025289. doi: 10.1161/JAHA.122.025289. Epub 2022 May 27.
7
Stem cell therapy for COVID-19 pneumonia.新冠肺炎的干细胞治疗
Mol Biomed. 2022 Feb 17;3(1):6. doi: 10.1186/s43556-021-00067-8.
8
Mortality and Severity in COVID-19 Patients on ACEIs and ARBs-A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.使用血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体阻滞剂的新冠肺炎患者的死亡率和严重程度——一项系统评价、荟萃分析和荟萃回归分析
Front Med (Lausanne). 2022 Jan 10;8:703661. doi: 10.3389/fmed.2021.703661. eCollection 2021.
9
The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice.血管紧张素受体阻滞剂对高血压住院患者 COVID-19 严重程度和高血压 hACE2 转基因小鼠中 SARS-CoV-2 毒力的影响。
J Cardiovasc Transl Res. 2022 Feb;15(1):38-48. doi: 10.1007/s12265-021-10147-3. Epub 2022 Jan 1.
10
Hypertension Update: A Reflection of the Past Decade.高血压最新进展：过去十年的回顾
Hypertension. 2021 Dec;78(6):1670-1673. doi: 10.1161/HYPERTENSIONAHA.121.18596. Epub 2021 Nov 10.